Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Haleon PLC Sponsored ADR (HLN : NYSE)
 
 • Company Description   
Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom.

Number of Employees: 24,561

 
 • Price / Volume Information   
Yesterday's Closing Price: $10.11 Daily Weekly Monthly
20 Day Moving Average: 12,236,326 shares
Shares Outstanding: 4,492.23 (millions)
Market Capitalization: $45,416.41 (millions)
Beta: 0.25
52 Week High: $11.42
52 Week Low: $8.68
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.17% -11.61%
12 Week -1.08% -16.79%
Year To Date 5.97% -0.75%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING 5 FIRST FLOOR THE HEIGHTS
-
WEYBRIDGE,X0 KT13 0NY
GBR		 ph: 44-0-19-3295-9500
fax: -		 investor-relations@haleon.com http://www.haleon.com
 
 • General Corporate Information   
Officers
Brian McNamara - Chief Executive Officer
Dave Lewis - Chairman
Dawn Allen - Chief Financial Officer
Amanda Mellor - Company Secretary
Tracy Clarke - Director

Peer Information
Haleon PLC Sponsored ADR (BJCT)
Haleon PLC Sponsored ADR (CADMQ)
Haleon PLC Sponsored ADR (APNO)
Haleon PLC Sponsored ADR (UPDC)
Haleon PLC Sponsored ADR (IMTIQ)
Haleon PLC Sponsored ADR (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 405552100
SIC: 2844
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/24
Next Expected EPS Date: 08/07/25
Share - Related Items
Shares Outstanding: 4,492.23
Most Recent Split Date: (:1)
Beta: 0.25
Market Capitalization: $45,416.41 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.46%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.25
Current Fiscal Year EPS Consensus Estimate: $0.50 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 7.03% Last Dividend Paid: 04/25/2025 - $0.12
Next EPS Report Date: 08/07/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.42
Trailing 12 Months: 25.92
PEG Ratio: 2.90
Price Ratios
Price/Book: 2.21
Price/Cash Flow: 20.28
Price / Sales: 3.16
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -64.29%
Sales Growth
vs. Year Ago Period: 2.92%
vs. Previous Quarter: -2.23%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - 17.65
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - 8.58
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 0.98
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 0.78
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - 12.86
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - 12.86
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - 17.00
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - 4.58
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - 6.70
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - 0.53
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - 34.75
 

Powered by Zacks Investment Research ©